53 results on '"Kochar, Bharati"'
Search Results
2. Pharmacoequity for Older Adults With Inflammatory Bowel Diseases
3. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon
4. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon
5. Underrepresentation of Racial and Ethnic Minorities in High-Impact Cirrhosis Clinical Trials
6. Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases
7. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study
8. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals
9. Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults
10. Tu1435: TOFACITINIB IS NOT ASSOCIATED WITH A HIGHER RISK OF THROMBOTIC AND CARDIOVASCULAR EVENTS COMPARED WITH ANTITUMOR NECROSIS FACTORS AGENTS IN PATIENTS WITH IBD
11. Mo1548: RISK OF INFECTIONS WITH USTEKINUMAB AND TOFACITINIB COMPARED TO TUMOR NECROSIS FACTOR ANTANOGISTS IN INFLAMMATORY BOWEL DISEASES
12. 580: ASSOCIATION OF PROTON PUMP INHIBITOR USE AND COGNITIVE DECLINE AND INCIDENT DEMENTIA IN OLDER ADULTS
13. 455: COMORBIDITY INFLUENCES THE COMPARATIVE SAFETY OF BIOLOGIC THERAPY IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES
14. The Association between Polypharmacy, Frailty and Disability-Free Survival in Community-Dwelling Healthy Older Individuals
15. Yield and Predictors of surveillance colonoscopies in older adults with long-standing ulcerative colitis
16. Sa557 TRANSMURAL INFLAMMATION, ILEITIS, AND GRANULOMAS AT THE TIME OF PROCTOCOLECTOMY DO NOT PREDICT FUTURE DEVELOPMENT OF POUCHITIS
17. Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data
18. COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR AGENTS IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES IN MEDICARE ADMINISTRATIVE CLAIMS DATABASE
19. Reply
20. Body Image Dissatisfaction among Pediatric Patients with Inflammatory Bowel Disease
21. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases
22. Mo1843 CREATION OF A NOVEL CASE-FINDING DEFINTION FOR IDENTIFYING PATIENTS WITH ACUTE POUCHITIS IN ADMINISTRATIVE CLAIMS DATA
23. Su1972 INCIDENCE OF POUCHITIS AND ANTIBIOTIC PRESCRIBING PATTERNS IN THE BIOLOGIC ERA
24. 281 FRAILITY IS ASSOCIATED WITH AN INCREASED RISK OF INFECTIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNOSUPPRESSION
25. Sa1830 FRAILITY IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
26. Sa1778 – Increased Risk of Meningitis in Patients with Inflammatory Bowel Diseases
27. Tofacitinib for the Treatment of Pyoderma Gangrenosum
28. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
29. Sa1706 - Current Status of Home Infusions for Inflammatory Bowle Disease in the United States
30. 275 - The National Experience with Vedolizumab
31. Mo1825 - Patterns of use of Psychotropic and Opioid Pain Medications in a Large Internet Cohort of Patients with Inflammatory Bowel Disease
32. Tu1718 - Body Image Dissatisfaction in Pediatric Patients with Inflammatory Bowel Diseases
33. Su1883 - Older age at the Time of Ileal Pouch-Anal Anastomosis Surgery is Associated with Chronic Antibiotic Dependent Pouchitis in a Multidisciplinary Inflammatory Bowel Disease Center
34. 11 DELAYED ILEAL POUCH ANAL ANASTOMOSIS HAS A LOWER 30-DAY ADVERSE EVENT RATE: ANALYSIS FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM
35. P015 BODY IMAGE DISSATISFACTION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
36. P140 CURRENT STATUS OF HOME INFUSIONS FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
37. The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease
38. Self-Report is not a Sensitive Method of Assessing Depression in Patients with Inflammatory Bowel Disease
39. Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease
40. High Burden of Persistent Gastrointestinal Symptoms andOngoing Morbidity in Patients with Esophageal Atresia and Tracheoesophageal Fistula
41. Factors Impacting Patient Reported Health-Related Quality of Life in Adolescents and Adults with Esophageal Atresia and Tracheoesophageal Fistula
42. The First Prospective National Evaluation of 30 Day Complication Rates of Ileal-Pouch Anal Anastomosis Procedures
43. Variations in Therapy for Inflammatory Bowel Disease among African American Patients Compared to other Racial Groups
44. A Diagnosis of Eosinophilic Esophagitis is Associated with Increased Life Insurance Premiums
45. Differences in Phenotype and Hospital Length of Stay Among Minority Pediatric Populations with Inflammatory Bowel Disease in a Nationwide Analysis
46. Endoscopic Findings in Eosinophilic Esophagitis and Esophageal Distensibility: A Proxy for Transmural Modeling?
47. Mo1174 Risk of Relapse After Successful Steroid Treatment in Eosinophilic Esophagitis Depends on Initial Steroid Dose
48. Mo1175 Diminishing Effectiveness of Maintenance Topical Steroid Therapy on Long-term Endoscopic and Histologic Outcomes in Eosinophilic Esophagitis
49. 800 Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Patients with Crohn's Disease in CCFA Partners
50. Totally One-sided: Painless Unilateral Proptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.